Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FQX34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,041
Award facts
- Contract value 100% obligated
- $1,041.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of June 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement that extends through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs worldwide.
Repatha is a prescription medication used for cholesterol management and cardiovascular disease prevention, supplied in this instance through AmerisourceBergen's established distribution network to support Defense Health Agency and related military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated extensive capability in fulfilling diverse pharmaceutical and medical supply requirements through its competitive contract awards with the DLA Medical Supply Chain. The company's federal contracting history reflects a robust portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQX34?
SPE2DB25FQX34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FQX34 worth?
The government has obligated $1,041 on SPE2DB25FQX34.
Is contract SPE2DB25FQX34 an order under another contract?
Yes. SPE2DB25FQX34 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQX34 competed?
The extent of competition for SPE2DB25FQX34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award